Gilead Sciences Inc.

Gilead Sciences, a biotech leader, develops & markets premium therapies—HIV (Biktarvy), COVID‑19 (Veklury), and oncology (Yescarta, Trodelvy)—while partnering with major pharma to expand its global pipeline.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Professional Services
Industry: Biotechnology Research

Employees: 17,600
HQ: Foster City

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
GILD	Gilead Sciences Inc. Cap: 168.7B \| P/E: 21.0	EQUITY	NMS	USD	US3755581036	Active	📈